| Summary: | 碩士 === 國立中山大學 === 企業管理學系研究所 === 88 === Although the pharmaceutical industry in Taiwan is not at large, there exist such two hundreds companies in this industry. In the past decade, such industrial development is unable to keep up with those of more developed countries, for instance, the United States and the United Kingdom.
A few reasons behind such fact are due to the high barriers on research and development of the pharmaceutical industry. For those larger pharmaceutical companies, investments on research and development are continuously being attempted. Though such attempted level cannot be compared with those pharmaceutical industries from abroad, it serves as a fine learning model for other companies particularly those of smaller ones to take into considerations. The primary goal behind the study is to explore the development and research of the pharmaceutical industry. Furthermore, such finding could provide an important source for other companies and for the government in the future if they plan to develop such type of industry.
In order to carry out the study, interview method suggested by the experts will be utilized. First and foremost, related documents and sources on the pharmaceutical industry field both including the developing and technical aspect will be collected.
The major points will then be sorted and organized for further study. Next, those managers who specialize in this area will be interviewed; and their opinions and their methodological recognitions will then be analyzed.
The study shows that most of these companies belong to the so called small and medium size enterprises. Their methods of modeling acquisition are decisions made by the top managers depending and according to the different situations and different cases. Most companies perceive some common factors like economical motivation, technical motivation and copyright and patent rights as the problems to be emphasized more. Finally, nine questions, comments and related discussion topics from the study are presented.
In conclusion, this study suggests two aspects for further research. One is to analyze the feasibility on the possible integration of large-scale pharmaceutical companies in Taiwan and the second one is to develop policies for research and development of pharmaceutical industry. This is to further expand the purpose behind the research.
|
|---|
